Meta-analysis approaches for Phase I dose finding early phases clinical trials in order to better suit requirements in terms of maximum tolerated dose (MTD) and maximal dose regimen (MDR). This package has currently three different approaches: (a) an approach proposed by Zohar et al, 2011, <doi:10.1002/sim.4121> (denoted as ZKO), (b) the Variance Weighted pooling analysis (called VarWT) and (c) the Random Effects Model Based (REMB) algorithm, where user can input his/her own model based approach or use the existing random effect logistic regression model (named as glimem) through the 'dfmeta' package.
|Author||Artemis Toumazi <email@example.com>, Sarah Zohar <firstname.lastname@example.org>, Anand N. Vidyashankar <email@example.com>, Jie Xu <firstname.lastname@example.org> and Moreno Ursino <email@example.com>|
|Maintainer||Artemis Toumazi <firstname.lastname@example.org>|
|License||GPL (>= 3) | file LICENSE|
|Package repository||View on CRAN|
Install the latest version of this package by entering the following in R:
Any scripts or data that you put into this service are public.
Add the following code to your website.
For more information on customizing the embed code, read Embedding Snippets.